A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung diseaseMasaki Hanibuchi, Yasuhiko Nishioka, Shinji Atagi et al.|Lung Cancer|2018Cited by 31